Logo image of ROGS.OL

ROGALAND SPAREBANK (ROGS.OL) Stock Fundamental Analysis

OSL:ROGS - Euronext Oslo - NO0006001007 - Common Stock - Currency: NOK

128.5  -1.5 (-1.15%)

Fundamental Rating

3

Overall ROGS gets a fundamental rating of 3 out of 10. We evaluated ROGS against 95 industry peers in the Banks industry. ROGS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ROGS is valued expensive at the moment. ROGS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ROGS was profitable.
In the past year ROGS has reported a negative cash flow from operations.
Each year in the past 5 years ROGS has been profitable.
In the past 5 years ROGS reported 4 times negative operating cash flow.
ROGS.OL Yearly Net Income VS EBIT VS OCF VS FCFROGS.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

ROGS has a Return On Assets (0.86%) which is comparable to the rest of the industry.
ROGS has a Return On Equity (8.02%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.86%
ROE 8.02%
ROIC N/A
ROA(3y)0.62%
ROA(5y)0.6%
ROE(3y)5.81%
ROE(5y)5.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROGS.OL Yearly ROA, ROE, ROICROGS.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

The Profit Margin of ROGS (28.86%) is better than 78.95% of its industry peers.
In the last couple of years the Profit Margin of ROGS has remained more or less at the same level.
ROGS does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 28.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.15%
PM growth 5Y0.02%
GM growth 3YN/A
GM growth 5YN/A
ROGS.OL Yearly Profit, Operating, Gross MarginsROGS.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

ROGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ROGS has more shares outstanding
The number of shares outstanding for ROGS has been reduced compared to 5 years ago.
ROGS has a better debt/assets ratio than last year.
ROGS.OL Yearly Shares OutstandingROGS.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ROGS.OL Yearly Total Debt VS Total AssetsROGS.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

ROGS has a Debt/Equity ratio of 4.14. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ROGS (4.14) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.96%
ROGS.OL Yearly LT Debt VS Equity VS FCFROGS.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ROGS.OL Yearly Current Assets VS Current LiabilitesROGS.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

ROGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
The Earnings Per Share has been growing by 10.81% on average over the past years. This is quite good.
ROGS shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.05%.
The Revenue has been growing by 9.48% on average over the past years. This is quite good.
EPS 1Y (TTM)32%
EPS 3Y15.8%
EPS 5Y10.81%
EPS Q2Q%19.05%
Revenue 1Y (TTM)51.05%
Revenue growth 3Y16.73%
Revenue growth 5Y9.48%
Sales Q2Q%17.87%

3.2 Future

ROGS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.27% yearly.
Based on estimates for the next years, ROGS will show a small growth in Revenue. The Revenue will grow by 1.96% on average per year.
EPS Next Y-6.75%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
EPS Next 5YN/A
Revenue Next Year2.04%
Revenue Next 2Y1.9%
Revenue Next 3Y1.96%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ROGS.OL Yearly Revenue VS EstimatesROGS.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ROGS.OL Yearly EPS VS EstimatesROGS.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.73, the valuation of ROGS can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ROGS indicates a slightly more expensive valuation: ROGS is more expensive than 70.53% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.79, ROGS is valued rather cheaply.
A Price/Forward Earnings ratio of 10.44 indicates a reasonable valuation of ROGS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ROGS indicates a slightly more expensive valuation: ROGS is more expensive than 67.37% of the companies listed in the same industry.
ROGS is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.73
Fwd PE 10.44
ROGS.OL Price Earnings VS Forward Price EarningsROGS.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROGS.OL Per share dataROGS.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

A cheap valuation may be justified as ROGS's earnings are expected to decrease with -2.27% in the coming years.
PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.39%, ROGS is a good candidate for dividend investing.
ROGS's Dividend Yield is rather good when compared to the industry average which is at 5.47. ROGS pays more dividend than 84.21% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.51, ROGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.39%

5.2 History

The dividend of ROGS is nicely growing with an annual growth rate of 16.29%!
Dividend Growth(5Y)16.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

ROGS pays out 71.05% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of ROGS has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.05%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
ROGS.OL Yearly Income VS Free CF VS DividendROGS.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
ROGS.OL Dividend Payout.ROGS.OL Dividend Payout, showing the Payout Ratio.ROGS.OL Dividend Payout.PayoutRetained Earnings

ROGALAND SPAREBANK

OSL:ROGS (4/25/2025, 7:00:00 PM)

128.5

-1.5 (-1.15%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-08 2025-05-08
Inst Owners30.64%
Inst Owner ChangeN/A
Ins Owners6.82%
Ins Owner ChangeN/A
Market Cap3.22B
Analysts80
Price Target145.52 (13.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.39%
Yearly Dividend11.09
Dividend Growth(5Y)16.29%
DP71.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.96%
Min EPS beat(2)8.29%
Max EPS beat(2)63.64%
EPS beat(4)3
Avg EPS beat(4)18.46%
Min EPS beat(4)-2.31%
Max EPS beat(4)63.64%
EPS beat(8)4
Avg EPS beat(8)12.88%
EPS beat(12)6
Avg EPS beat(12)7.16%
EPS beat(16)9
Avg EPS beat(16)10.67%
Revenue beat(2)1
Avg Revenue beat(2)8.11%
Min Revenue beat(2)-6.12%
Max Revenue beat(2)22.35%
Revenue beat(4)2
Avg Revenue beat(4)4.29%
Min Revenue beat(4)-6.12%
Max Revenue beat(4)22.35%
Revenue beat(8)4
Avg Revenue beat(8)5.19%
Revenue beat(12)6
Avg Revenue beat(12)5.28%
Revenue beat(16)10
Avg Revenue beat(16)4.56%
PT rev (1m)0.71%
PT rev (3m)18.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.34%
EPS NY rev (3m)1.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.8%
Valuation
Industry RankSector Rank
PE 9.73
Fwd PE 10.44
P/S 2.71
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)13.2
EY10.27%
EPS(NY)12.31
Fwd EY9.58%
FCF(TTM)-20.26
FCFYN/A
OCF(TTM)-20.23
OCFYN/A
SpS47.48
BVpS170.8
TBVpS170.58
PEG (NY)N/A
PEG (5Y)0.9
Profitability
Industry RankSector Rank
ROA 0.86%
ROE 8.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.86%
GM N/A
FCFM N/A
ROA(3y)0.62%
ROA(5y)0.6%
ROE(3y)5.81%
ROE(5y)5.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.15%
PM growth 5Y0.02%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC5.96%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y15.8%
EPS 5Y10.81%
EPS Q2Q%19.05%
EPS Next Y-6.75%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
EPS Next 5YN/A
Revenue 1Y (TTM)51.05%
Revenue growth 3Y16.73%
Revenue growth 5Y9.48%
Sales Q2Q%17.87%
Revenue Next Year2.04%
Revenue Next 2Y1.9%
Revenue Next 3Y1.96%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-262.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-264.21%
OCF growth 3YN/A
OCF growth 5YN/A